Tamoxifen Tablets
Tamoxifen tablets for breast cancer. It blocks oestrogen that some breast cancers rely on to grow.
- Category
- Oncology Support
- Active ingredient
- Tamoxifen
- Route
- Oral use
- Form
- Tablet
- Strengths
- 20mg
A generic with the stated active ingredient and strength. The maker is confirmed before dispatch.
Supply requirements for Tamoxifen Tablets depend on the medicine and destination. The fulfilment partner must confirm them before accepting an order.
Tamoxifen Tablets details
- Condition
- Breast Cancer
- Alternative names
- nolvadex
- Therapeutic class
- Selective Oestrogen Receptor Modulator (SERM)
- Pharmacological class
- Antineoplastic
- Known off-label uses
- ovulation induction
- Contraindications
- pregnancy; history of deep vein thrombosis; concurrent coumarin anticoagulants
- Minor side effects
- hot flushes; nausea; fatigue
- Moderate side effects
- vaginal discharge; fluid retention; menstrual irregularities
- Dosage forms
- Tablet
- Administration route
- Oral use
- Supply category
- Prescription-only medicine (POM)
- Onset Time
- 4–8 weeks
- Duration
- 24 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- Warfarin; Rifampin; Paroxetine
- Age restrictions
- Approved for adults.
Serious side effects
venous thromboembolism, requires immediate medical attention; endometrial cancer, requires immediate medical attention
Patient summary
Tamoxifen tablets for breast cancer. It blocks oestrogen that some breast cancers rely on to grow.
Mechanism of action
Competitively blocks oestrogen receptors in breast tumour tissues, preventing cell transcription and tumour proliferation.
Pregnancy and breastfeeding
Pregnancy: Highly teratogenic. Do not use in pregnancy. Breastfeeding: Contraindicated.
What you will receive
Tamoxifen Tablets is a generic, listed by its active ingredient, Tamoxifen.
- The maker is confirmed before dispatch.
- Check the active ingredient, strength, form, pack, seal, batch and expiry details.